TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33506314

Group type: EXPERIMENTAL
Intervention: Oral calcifediol 20 µg/day
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral calcifediol 30 µg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 50
Study: 35809362

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (TE2)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Transdermal placebo
Number of subjects: 73
Study: 33771116

Group type: EXPERIMENTAL
Intervention: Isotonic saline (IS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: PlasmaLyte (PL)
Number of subjects: 38
Study: 32079472

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 35843037

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) fiber
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 29
Study: 33780655

Group type: EXPERIMENTAL
Intervention: Large facilities
Number of subjects: 17194

Group type: COMPARATOR
Intervention: Smaller facilities
Number of subjects: 17194

Group type: EXPERIMENTAL
Intervention: Not independently mobile
Number of subjects: 17194

Group type: EXPERIMENTAL
Intervention: Male residents
Number of subjects: 17194

Group type: EXPERIMENTAL
Intervention: Residents with dementia
Number of subjects: 17194

Group type: EXPERIMENTAL
Intervention: Random selection of participants
Number of subjects: 17194
Study: 32390168

Group type: EXPERIMENTAL
Intervention: ICI monotherapy (nivolumab: 44.3%, pembrolizumab: 11.7%, ipilimumab: 23.6%)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: ICI combination therapy
Number of subjects: 451

Group type: COMPARATOR
Intervention: Definite PAI
Number of subjects: 451

Group type: COMPARATOR
Intervention: Possible PAI
Number of subjects: 451
Study: 35758433

Group type: EXPERIMENTAL
Intervention: Parenchyma-sparing resections (PSR)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Oncologic resections
Number of subjects: 810

Group type: COMPARATOR
Intervention: No lymph nodes resected
Number of subjects: 810
Study: 32023539

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (5,000 IU daily for 12 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (daily for 12 weeks)
Number of subjects: 19
Study: 36309971

Group type: EXPERIMENTAL
Intervention: PB-201
Number of subjects: 672

Group type: COMPARATOR
Intervention: Vildagliptin
Number of subjects: 672

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 672
Study: 34281913

Group type: EXPERIMENTAL
Intervention: Low-dose atorvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32699287

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HW) 1.5 L/d for 4 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Plain water (PW)
Number of subjects: 38
Study: 35761257

Group type: EXPERIMENTAL
Intervention: Brushing carried out by trained laypeople using manual toothbrush
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Brushing carried out by trained laypeople using powered toothbrush
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Brushing carried out by dental professionals using manual toothbrush
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Brushing carried out by dental professionals using powered toothbrush
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 39
Study: 34118150

Group type: EXPERIMENTAL
Intervention: Perceval bioprosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard sutured stented bioprosthetic aortic valve
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 32565465

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v probiotic therapy in addition to usual care
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo in addition to usual care
Number of subjects: 220
Study: 32930640

Group type: EXPERIMENTAL
Intervention: Smartphone group (SMA), n = 11, used social network smartphone apps for 30 minutes before training.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (CON), n = 11, watched Olympic Games videos for 30 minutes before training.
Number of subjects: 22
Study: 33528922

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.2 to 1.5 μg/kg/hour)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Propofol (5 to 50 μg/kg/min)
Number of subjects: 422
Study: 35278403

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32299733

Group type: EXPERIMENTAL
Intervention: G-Series media system with antioxidants (A3 group)
Number of subjects: 133

Group type: COMPARATOR
Intervention: G-Series media system (control)
Number of subjects: 133
Study: 36305584

Group type: EXPERIMENTAL
Intervention: Active system
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sham system
Number of subjects: 65
Study: 34656099

Group type: EXPERIMENTAL
Intervention: TruNatomy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProTaper GOLD
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: WaveOne GOLD
Number of subjects: 60
Study: 33074237

Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 35857978

Group type: EXPERIMENTAL
Intervention: Standard inner limiting membrane peeling
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Inner limiting membrane peeling with abrasion technique
Number of subjects: 59
Study: 34397951

Group type: EXPERIMENTAL
Intervention: Packed red blood cells (PRBCs) transfusion
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Quantity of PRBCs transfused
Number of subjects: 399
Study: 32539705

Group type: EXPERIMENTAL
Intervention: ESRD patients with depression
Number of subjects: 30
Study: 35404772

Group type: EXPERIMENTAL
Intervention: Interruption of sedatives
Number of subjects: 85

Group type: COMPARATOR
Intervention: Volume assist-control mode
Number of subjects: 85

Group type: COMPARATOR
Intervention: Pressure support mode
Number of subjects: 85
Study: 32583630

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 60
Study: 35613997

Group type: EXPERIMENTAL
Intervention: CCRT plus pembrolizumab (Group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: CCRT plus pembrolizumab with olaparib (Group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: CCRT plus placebo (Group C)
Number of subjects: 150
Study: 33970327

Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (CF) 400 mg for 7 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 17
Study: 35120559

Group type: EXPERIMENTAL
Intervention: Structured learning program, prehospital NIHSS, and a mobile application facilitating communication with the stroke physician.
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Standard procedures (control phase).
Number of subjects: 1300
Study: 33959750

Group type: EXPERIMENTAL
Intervention: Inoculant (INO) containing Lactobacillus buchneri and Pediococcus pentosaceus (4 × 10^5 and 1 × 10^5 cfu/g of fresh corn)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (CON) without inoculant
Number of subjects: 6
Study: 32356923

Group type: EXPERIMENTAL
Intervention: Randomized security checks (30% screened)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized security checks (90% screened)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional security checks
Number of subjects: 0
Study: 35453121

Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 11

Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 11
Study: 35024014

Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 60
Study: 36229117

Group type: EXPERIMENTAL
Intervention: iSOMA guided (8-week intervention with regular, written therapeutic guidance)
Number of subjects: 149

Group type: COMPARATOR
Intervention: iSOMA-GoD (guidance-on-demand after waitlist control)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Both treatments (iSOMA guided and iSOMA-GoD)
Number of subjects: 149
Study: 33336703

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound (RTUS) visual feedback with manual facilitation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual facilitation alone
Number of subjects: 25
Study: 34590986

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral-integrated musical rhythms intervention, conducted over five sessions.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (not specified in the abstract).
Number of subjects: 38
Study: 34237458

Group type: EXPERIMENTAL
Intervention: Experimental placebo manipulations (e.g., positive expectations, time spent with subjects, training for accurate symptom reporting)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventions that neutralize staff and subject expectations and improve reporting accuracy
Number of subjects: 0
Study: 32000687

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both LC and CC
Number of subjects: 50
Study: 34348574

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 1048

Group type: COMPARATOR
Intervention: Secukinumab 300 mg
Number of subjects: 1048
Study: 33048477

Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (Control)
Number of subjects: 10
Study: 32147444

Group type: EXPERIMENTAL
Intervention: Home exercise plus motor imagery
Number of subjects: 37

Group type: COMPARATOR
Intervention: Only home exercise
Number of subjects: 37
Study: 36326471

Group type: EXPERIMENTAL
Intervention: Prazosin (0.05 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32041632

Group type: EXPERIMENTAL
Intervention: Vitamin D deficient children (serum 25(OH)D < 12 ng/ml)
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Vitamin D inadequate children (serum 25(OH)D 12-20 ng/ml)
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Vitamin D sufficient children (serum 25(OH)D > 20 ng/ml)
Number of subjects: 791
Study: 35768894

Group type: EXPERIMENTAL
Intervention: Intervention based on reciprocity
Number of subjects: 17930

Group type: EXPERIMENTAL
Intervention: Intervention based on scarcity
Number of subjects: 17930

Group type: EXPERIMENTAL
Intervention: Intervention based on authority
Number of subjects: 17930
Study: 34429160

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID + MTX
Number of subjects: 1146

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week + MTX
Number of subjects: 1146
Study: 35289857

Group type: EXPERIMENTAL
Intervention: Tumor necrosis factor inhibitors (TNFis) for at least 12 weeks
Number of subjects: 1899

Group type: EXPERIMENTAL
Intervention: Higher C-reactive protein (CRP) level, patient global assessment (PGA), and Bath AS Disease Activity Index (BASDAI) question 2 score
Number of subjects: 1899

Group type: EXPERIMENTAL
Intervention: Higher body mass index (BMI) and Bath AS Functional Index (BASFI) score
Number of subjects: 1899

Group type: EXPERIMENTAL
Intervention: Age and BASFI score
Number of subjects: 1899

Group type: EXPERIMENTAL
Intervention: Higher CRP level, BASDAI question 2 score, and PGA
Number of subjects: 1899
Study: 32066436

Group type: EXPERIMENTAL
Intervention: Arthroscopic lateral patella retinaculum releasing outside synovial membrane (OSM)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Arthroscopic lateral patella retinaculum releasing through synovial membrane (TSM)
Number of subjects: 125
Study: 34103514

Group type: EXPERIMENTAL
Intervention: Neuroscience publications from African institutions
Number of subjects: 5219

Group type: COMPARATOR
Intervention: Publications from the UK, USA, Australia, Japan, and Brazil (control group)
Number of subjects: 5219
Study: 32659854

Group type: EXPERIMENTAL
Intervention: Below-epiglottis transnasal tube insertion
Number of subjects: 60
Study: 34385272

Group type: EXPERIMENTAL
Intervention: BI 1265162 200 µg twice daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32892245

Group type: EXPERIMENTAL
Intervention: Double-spin prepared PRP injection
Number of subjects: 15

Group type: COMPARATOR
Intervention: Single-spin prepared PRP injection
Number of subjects: 15
Study: 36317099

Group type: EXPERIMENTAL
Intervention: Primary sternal closure
Number of subjects: 217

Group type: COMPARATOR
Intervention: Vacuum-assisted closure
Number of subjects: 217
Study: 32660025

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (L. plantarum, L. bulgaricus, L. gasseri, B. breve, B. animalis sbsp. lactis, B. bifidum, S. thermophilus, and S. boulardii)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34906756

Group type: EXPERIMENTAL
Intervention: Numen coil
Number of subjects: 350

Group type: COMPARATOR
Intervention: Axium coil
Number of subjects: 350
Study: 34244750

Group type: EXPERIMENTAL
Intervention: Intervention group (IG) with clinical pharmacist's interventions
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group (CG) without clinical pharmacist's interventions
Number of subjects: 256
Study: 32816144

Group type: EXPERIMENTAL
Intervention: Cooling vest (COLD)
Number of subjects: 10
Study: 33739404

Group type: EXPERIMENTAL
Intervention: Rd-R (lenalidomide 10 mg per day without dexamethasone)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Continuous Rd
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Rd-R
Number of subjects: 199
Study: 35668682

Group type: EXPERIMENTAL
Intervention: M. alternifolia pure essential oil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: M. alternifolia Nanoemulsion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle formulation
Number of subjects: 40
Study: 34313609

Group type: EXPERIMENTAL
Intervention: Hypercapnia (n=23)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normocapnia (n=23)
Number of subjects: 50
Study: 32805259

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 116

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Low NAS severity cluster
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: High NAS severity cluster
Number of subjects: 116
Study: 35546664

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonists (albiglutide, exenatide, liraglutide, semaglutide, lixisenatide, dulaglutide)
Number of subjects: 52821

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52821
Study: 32748415

Group type: EXPERIMENTAL
Intervention: Physical and psychological abuse exposure
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Multiple forms of abuse (physical and psychological) exposure
Number of subjects: 600

Group type: COMPARATOR
Intervention: Non-abused controls
Number of subjects: 600
Study: 32236398

Group type: EXPERIMENTAL
Intervention: Rice wine lees (RWL)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 36087550

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 and 300 mg every 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33929326

Group type: EXPERIMENTAL
Intervention: e-learning program about best practice knee OA management via telehealth delivery
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: mock video consultation with a researcher and 4 audited practice video consultations with pilot patients
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: self-directed learning modules
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: overall e-learning program
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: training program
Number of subjects: 15
Study: 33166722

Group type: EXPERIMENTAL
Intervention: pegilodecakin + pembrolizumab
Number of subjects: 153

Group type: COMPARATOR
Intervention: pembrolizumab
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: pegilodecakin + nivolumab
Number of subjects: 153

Group type: COMPARATOR
Intervention: nivolumab
Number of subjects: 153
Study: 32375735

Group type: EXPERIMENTAL
Intervention: Primary surgery followed by systemic therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Primary systemic therapy without surgery
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Younger women in both groups
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Baseline global health status and physical functioning
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Global health status, social functioning scale, breast symptoms and future perspective
Number of subjects: 90
Study: 36378077

Group type: EXPERIMENTAL
Intervention: 150iu BD of formulated regular insulin in enteric-coated capsules
Number of subjects: 100

Group type: COMPARATOR
Intervention: 75iu BD of formulated regular insulin in enteric-coated capsules
Number of subjects: 100

Group type: COMPARATOR
Intervention: 300iu BD of formulated regular insulin in enteric-coated capsules
Number of subjects: 100

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 100
Study: 32698233

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Lugol chromoendoscopy
Number of subjects: 334
Study: 32504694

Group type: EXPERIMENTAL
Intervention: 48‐h zero‐calorie diet with water provided ad libitum
Number of subjects: 11

Group type: COMPARATOR
Intervention: 48‐h usual diet
Number of subjects: 11
Study: 35758031

Group type: EXPERIMENTAL
Intervention: Mirabegron (300 mg daily)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 34136900

Group type: EXPERIMENTAL
Intervention: STIMULAX (oral Coloxyl® with senna and macrogol, with sodium phosphate enema for right-sided operations)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control (standard ERP postoperative care)
Number of subjects: 170
Study: 35544473

Group type: EXPERIMENTAL
Intervention: Lipid/insulin infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study: 33206462

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (25 mg)
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2629
Study: 36063401

Group type: EXPERIMENTAL
Intervention: Standardized instructions for TKV measurement
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non-standardized instructions for TKV measurement
Number of subjects: 49
Study: 33074326

Group type: COMPARATOR
Intervention: FOLFOX4
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: FOLFOX4 with bevacizumab
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: XELOX with bevacizumab
Number of subjects: 573
Study: 35965453

Group type: EXPERIMENTAL
Intervention: Health promotion program in addition to standard care
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study: 33319454

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32464224

Group type: EXPERIMENTAL
Intervention: Higher-volume feedings (180-200 mL/kg/d)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual-volume feedings (140-160 mL/kg/d)
Number of subjects: 224
Study: 33951510

Group type: EXPERIMENTAL
Intervention: Socio-affective skills training (Affect module)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Attention and interoceptive awareness training (Presence module)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Socio-cognitive skills training (Perspective module)
Number of subjects: 332
Study: 32078754

Group type: EXPERIMENTAL
Intervention: Reflexology performed three times per day at every eight hours for 30 min for 3 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no reflexology)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 100
Study: 35906606

Group type: EXPERIMENTAL
Intervention: Blended training (online and face-to-face)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 20
Study: 33741284

Group type: EXPERIMENTAL
Intervention: Collagen sponge (Collacone)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Empty alveolus (control)
Number of subjects: 23
Study: 32701480

Group type: EXPERIMENTAL
Intervention: Peer education provided on the third day after MI, sessions lasted 90 to 120 minutes
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no peer education)
Number of subjects: 70
Study: 35898121

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction during venous cannulation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard of care (topical numbing cream, positioning, and distraction by games on tablet/smartphone)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups (VR and control)
Number of subjects: 106
Study: 34678198

Group type: EXPERIMENTAL
Intervention: Typhoid Conjugate Vaccine (TCV)
Number of subjects: 20019

Group type: COMPARATOR
Intervention: Capsular group A meningococcal conjugate vaccine (MenA)
Number of subjects: 20019
Study: 34561291

Group type: EXPERIMENTAL
Intervention: Biomarker-directed treatment adjustment
Number of subjects: 291

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Transition onto or off oral corticosteroids
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Emergency room attendance in the prior year
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Belonging to an ethnic minority group
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Prior study medication changes (two or more changes)
Number of subjects: 291
Study: 35797682

Group type: COMPARATOR
Intervention: Home Stretching (HS)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Physical Therapy (PT)
Number of subjects: 57
Study: 33412106

Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI 200/31·25/25 μg
Number of subjects: 748

Group type: COMPARATOR
Intervention: FF/VI 200/25 μg
Number of subjects: 748
Study: 32657376

Group type: EXPERIMENTAL
Intervention: Miniception randomized algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random minimizer
Number of subjects: 0
Study: 33608147

Group type: EXPERIMENTAL
Intervention: Prior musical experience
Number of subjects: 51

Group type: COMPARATOR
Intervention: Nonmusicians
Number of subjects: 51